Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Research Grant, 2010
    Longitudinal Follow-Up of Clinical and Neuroimaging Signs and Biomarkers in Symptoms & Side Effects and aSymptoms & Side Effects LRRK2 Mutation Carriers in Comparison to Idiopathic PD and Controls

    Objective/Rationale
    Parkinson’s disease (PD) is a common neurodegenerative disease that leads to progressive motor impairment as well as autonomic and cognitive disturbances. The cause of most of...

  • Alpha-Synuclein Therapeutics, 2010
    Testing of Davunetide for Intranasal Administration in Pre-clinical Models Over Expressing Alpha-synuclein

    Objective/Rationale
    Davunetide is an investigational drug with the potential to treat Parkinson disease and is currently in a clinical trial for progressive supranuclear palsy, a rare progressive...

  • Rapid Response Innovation Awards, 2010
    Ghrelin - a Peripheral, Preclinical Biomarker for Parkinson's Disease

    Promising Outcomes of Original Grant:
    In our original grant we investigated serum concentrations of the hormone ghrelin in the fasting state and at different time points after a standardized test meal...

  • Biomarkers, 2010
    Prospective Validation of Risk Markers for the Development of Parkinson’s Disease

    Promising Outcomes of Original Grant:
    As Parkinson’s disease is diagnosed when already a number of neurons have degenerated the PRIPS cohort consisting of 1847 healthy subjects older than 50 years was...

  • Rapid Response Innovation Awards, 2009
    Enhanced Delivery of Viral Vectors to Striatum with Solid-State Biodegradable Matrices

    Objective/Rationale
    When treating patients with neurological disorders, physicians frequently administer drugs through a small plastic tube or needle placed into the target area of the brain...

  • Clinical Intervention Awards, 2009
    NIC-PD Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease

    Objective/Rationale:
    No drugs are available that can slow or stop the progression of Parkinson’s disease (PD). Nicotine is a promising substance for this purpose. Firstly, epidemiological studies...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.